Purpose: Phospholipase A 2 (PLA 2 ) is a growing family of lipolytic enzymes that play a key role in various biological processes including general lipid metabolism, membrane homeostasis, and in diseases such as atherosclerosis, arthritis, and acute pancreatitis. Oxidative stress as well as inflammation may be associated with glaucoma pathogenesis. Therefore, our aim was to examine the expression of group IIA secretory PLA 2 (sPLA 2 -IIA), group V secretory PLA 2 (sPLA 2 -V), calcium-independent PLA 2 (iPLA 2 ), and cytosolic PLA 2 (cPLA 2 ) type in the trabecular meshwork (TM) and the canal of Schlemm in normal eyes and in juxtacanalicular tissue samples from patients with primary open angle glaucoma (POAG) or exfoliation glaucoma (ExG). Methods: TM tissues were isolated from healthy donor eyes for corneal transplantation. Specimens of inner wall of the Schlemm's canal and the juxtacanalicular tissue were collected during deep sclerectomy from the eyes of patients who had POAG or ExG. Antibodies against PLA 2 s (sPLA 2 -IIA, sPLA 2 -V, iPLA 2 , and cPLA 2 ) and a standard immunohistochemical procedure were used for the analysis. Quantification of immunoreactions was provided using a Photoshopbased image analysis. Double-staining immunofluorescence of macrophages and sPLA 2 -IIA was performed by using confocal microscopy. Results: sPLA 2 -IIA was not present in normal TM. In contrast, sPLA 2 -IIA levels were significantly higher in glaucoma patients than in controls. Furthermore, sPLA 2 -IIA expression was much higher in POAG when compared to ExG. iPLA 2 was found to predominate in normal human TM, and it demonstrated strong labeling in the uveal and corneoscleral meshwork. The staining of juxtacanalicular meshwork was only moderate in density. In contrast, expression of the enzyme was significantly decreased in glaucoma patients, especially in ExG, when compared to normal controls or to POAG. In addition, strong regional differences were detected in sPLA 2 -IIA and iPLA 2 levels in POAG, whereas immunostaining of these enzymes was much lower and rather uniform throughout ExG sample. In POAG, sPLA 2 -IIA staining was restricted to certain parts of the trabecular samples where sPLA 2 -IIA positive macrophages were also present. Immunostaining of sPLA 2 -V or cPLA 2 was low, and no significant changes were found in levels of these enzymes between normal and glaucomatous samples. Conclusions: sPLA 2 -IIA, an oxidative stress marker in atherosclerosis, is overexpressed especially in POAG. This result supports the hypothesis that oxidative stress may play a significant role in the pathogenesis of POAG. In ExG, a dramatic decrease in the expression level of iPLA 2 , a housekeeping enzyme in phospholipid remodeling, may indicate imbalance in phospholipid turnover and also inhibition of normal physiological functions in the TM. These findings may contribute to understanding the pathogenesis of POAG and ExG and may be important for the development of novel therapeutic strategies to different glaucomas.
The term glaucoma is used to describe a heterogeneous group of diseases that have in common a characteristic optic cup neuropathy with loss of visual field defects [1] . Elevated intraocular pressure (IOP) is a strong risk factor for open-angle glaucoma, but some patients with glaucoma have normal IOP and many patients with elevated IOP do not have glaucoma [2, 3] . In Finland and other Nordic countries, the most common types of glaucoma are primary open-angle glaucoma (POAG) and exfoliation glaucoma (ExG) [4] [5] [6] . Usually ExG is more aggressive; it reacts worse to medical treatment, and optic nerve damage and visual field loss take place earlier than in POAG [7] [8] [9] [10] [11] [12] . Elevated IOP in ExG may be attributed to accumulation of the exfoliation material or pigment particles in the angle chamber [13] [14] [15] . PLA 2 (EC 3.1.1.4) belongs to a superfamily of enzymes that catalyzes the hydrolysis of the sn-2 ester bond in phospholipids. The hydrolysis products are free fatty acids and lysophospholipids [16, 17] . Different PLA 2 isoenzymes have been found and classified into several groups (from I to XIV) based on their structures, subcellular distributions, cellular functions, and enzymatic characteristics [18, 19] . In a simplified classification system, PLA 2 s can be divided into four major groups: secretory PLA 2 (sPLA 2 ), Ca 2+ -independent PLA 2 (iPLA 2 ), cytosolic PLA 2 (cPLA 2 ), and a class of PLA 2 called platelet-activating factor (PAF) acetylhydrolase (PAF-AH) [20] [21] [22] . sPLA 2 is optimally active at millimolar Ca 2+ concentration and cPLA 2 requires micromolar amounts of Ca 2+ , whereas iPLA 2 does not need Ca 2+ for activity [23] . PLA 2 s play a key role in various biological processes. sPLA 2 has been implicated in the regulation of a wide array of cellular functions, such as arachidonic acid (AA) metabolism, ©2007 Molecular Vision Phospholipase A 2 in chamber angle of normal eyes and patients with primary open angle glaucoma and exfoliation glaucoma phospholipids digestion, extracellular matrix (ECM) remodeling, regulation of proliferation and cell contraction, endothelial cell migration, antimicrobial defense, and regulation of acrosome reaction of spermatozoa [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] . Elevated levels of sPLA 2 have been detected in several diseases including atherosclerosis, inflammatory diseases, arthritis, acute pancreatitis, and neurodegeneration [34] [35] [36] [37] [38] [39] . cPLA 2 is the only PLA 2 that shows significant selectivity toward AA at the sn-2 position of the phospholipid molecule [40] . Therefore, it plays an important role in mediating important cellular processes including eicosanoid biosynthesis [41] .
iPLA 2 is generally regarded as a housekeeping enzyme as it remodels and maintains membrane phospholipids [42] . Recent studies have suggested the enzyme has other roles. iPLA 2 has a proliferative effect and a functional role in cellular signaling cascades, vascular smooth muscle contraction, artery relaxation, and in apoptotic processes [43] [44] [45] [46] [47] [48] . Recently, it was reported that iPLA 2 is required for activation of storeoperated Ca 2+ channels to initiate Ca 2+ influx [49] . In general, mammalian cells contain more than one PLA 2 [17] thus there is considerable interest in determining the role of each PLA 2 . To our knowledge, although much research has been done to characterize, purify, and clone various forms of PLA 2 from diverse sources, virtually nothing has been presented about the existence of PLA 2 in the human anterior chamber angle. The anterior segment of the eye is filled with aqueous humor. A major component of the anterior chamber angle is the trabecular meshwork (TM) and the canal of Schlemm. The TM regulates the outflow facility of the aqueous humor and is also responsible for IOP control [50] . Recent notions that oxidative stress may play a role in glaucomatous TM cells have brought new insights to probable pathophysiologic mechanisms behind glaucoma [51] . Interestingly, PLA 2 s are important mediators of oxidative damage in cells [20, 39] . To fill this gap, the goal of the present study was to immunohistochemically analyze the expression of PLA 2 in normal human chamber angle and the inner wall of Schlemm's canal and the juxtacanalicular tissue of patients with POAG or ExG. In this work we used antibodies against four distinct PLA 2 s, including group IIA secretory PLA 2 (sPLA 2 -IIA), group V secretory PLA2 (sPLA 2 -V), iPLA 2 , and cPLA 2 .
METHODS

Materials:
Monoclonal antibodies against sPLA 2 -IIA were purchased from Upstate (Lake Placid, NY). Monoclonal antibodies against sPLA2-V and cPLA2 (sc-4-4B-3C, lot number E1704) and rabbit polyclonal antibodies against iPLA 2 Homogenization and western blot analysis of control samples: Low molecular weight standards were obtained from Amersham Biosciences. Normal human TM tissue samples were homogenized on ice in T-PER Tissue Protein Extraction Reagent with protease inhibitor coctail (Pierce, Rockford, IL). Proteins (10 µg) were separated by SDS-PAGE [52] , and after the run, the gels were subjected to western blot. Briefly, the samples were transferred (voltage: 12 V; current: 100 mA) to Hypond ECL (nitrocellulose) membranes (Amersham Biosciences) for 1 h using a semidry blotter (Transblot system, Bio-Rad, Hercules, CA). Transfer buffer was 25 mM Tris containing 192 mM glycine and 20% methanol. The membranes were blocked with 3% milk powder in phosphate-buffered saline (PBS) with 0.3% Tween for 1 h at 25 °C. After blocking the membranes were incubated overnight at 4 °C with antibodies directed against sPLA 2 -IIA, sPLA 2 -V, iPLA 2 , or cPLA 2 (each with 1:500 dilution in blocking solution). Membranes were washed in PBS with 0.3% Tween three times for 10 min each. Membranes were probed with the appropriate secondary antibody (antimouse IgG used at 1:50,000 dilution in blocking solution or antirabbit IgG used at 1:20,000 dilution in blocking solution) linked to horseradish peroxidase for 2 h. Membranes were then washed in PBS with 0.3% Tween three times for 10 min each. Proteins were visualized with Immobilon Western Chemiluminescent HPR substrate (Millipore, Billerica, MA) and exposed to Fuji RX film (Fuji, Japan). Purified recombinant human sPLA 2 -IIA (BioVendor GmbH, Heidelberg, Germany) and sPLA 2 -V (BioVendor, GmbH) were used as positive controls.
Immunohistochemistry: Cryosections were fixed in icecold acetone for 7 min, air-dried, then rinsed twice with tris-buffered saline (TBS). Paraffin sections were dewaxed in xylene and dehydrated in graded ethanols according to standard procedures. Immunostaining was carried out with HistostainTM-Plus Mouse Primary Bulk kit (Zymed Laboratories, South San Francisco, CA) or Histostain™-Plus Broad Spectrum Bulk kit (Zymed Laboratories) and with DAB substrate kit (Zymed Laboratories) following guidelines described in reference [53] . The antibodies for demonstrating sPLA 2 -V, iPLA 2 , and cPLA 2 were all used at a dilution of 1:100, and a dilution of 1:400 was used for sPLA 2 -IIA. The tissue sections were examined and digitally captured using a Nikon Eclipse TE300 inverted microscope (Nikon, Tokyo, Japan) equipped with Nikon E995 digital camera (Nikon), and the images were processed with Adobe Photoshop (version 5.5) software.
Confocal laser scanning microscopy: Double-immunofluorescence was performed for colocalization studies of sPLA 2 and macrophages using the method described in Kroeber et al. [54] . Primary antibodies used were anti-sPLA 2 -IIA (1:400 dilution) and anti-CD68 (1:10 dilution). sPLA 2 -IIA was detected with antimouse IgG Alexa Fluor 488 (1:200 dilution), and macrophages were detected with Alexa Fluor 594 (1:5 dilution; red fluorescence). In addition, nuclei were stained with a 1 mM solution of far red nucleic acid dye (SYTO 62; Molecular Probes).
For colocalization studies cryosections were fixed in icecold acetone for 7 min, air-dried, rinsed twice with TBS and blocked with blocking solution. Colocalization of sPLA 2 -IIA and macrophages was observed by merged images with UltraVIEW confocal imaging systems (PerkinElmer Life Sciences, Shelton, CT) following guidelines established in reference [55] . Sections were mounted on Vectashield mounting medium (Vector, Burtingame, CA). To verify an absence of ©2007 Molecular Vision Molecular Vision 2007; 13:408-17 <http://www.molvis.org/molvis/v13/a44/> Figure 1 . Immunohistochemical localization of PLA 2 s in normal human trabecular meshwork. Immunostaining for sPLA 2 -IIA (A) or sPLA 2 -V (B) was negative in the trabecular meshwork. Intense staining for sPLA 2 -IIA or sPLA 2 -V was evident in a few inflammatory-like cells (arrow). iPLA 2 immunolabeling was strong (C). Labeling of the uveal and corneoscleral meshwork was stronger compared to the staining of the juxtacanalicular meshwork. Low positive staining was seen in the apical parts of the cells lining Schlemm's canal (arrowhead) as well as in nearby extracellular regions. Positive staining was also seen in a few macrophages (arrow). Inset: A portion of trabecular meshwork lamellae at higher magnification. Uveal trabecular meshwork cells covering the lamellae were more intensely labeled compared to connective tissue core. cPLA 2 was weakly positive (D) and staining was slightly higher in uveal and corneoscleral meshwork compared to juxtacanalicular meshwork. The cells lining Schlemm's canal showed weak staining. Positive staining was seen in a few macrophages (arrow). AC, anterior chamber; SC, Schlemm's canal. The scale bar is equal to 50 µm. 410
cross-reaction between antibodies, we omitted each primary or secondary antibody from the incubation. All control experiments confirmed that there was no cross-reactivity between the antibodies. Quantification of immunohistochemical staining: The amount of antibody staining was quantified by using Photoshop-based image analysis [53] . All samples were analyzed in triplicate. The final immunostaining intensity (AU) was determined by subtracting the intensity of the negative control.
Statistical analysis: Differences between experimental groups were determined using the Mann-Whitney Rank Sum test (SigmaStat statistical software, SPSS Inc, Chicago, IL). A p less than or equal to 0.05 was considered statistically significant. Figure 1A ) or sPLA 2 -V ( Figure 1B ) immunohistochemical labeling was observed in few macrophages. In contrast, iPLA 2 demonstrated strong labeling of the uveal and corneoscleral meshwork, and the staining of juxtacanalicular meshwork was only moderate in density. Uveal TM cells covering the lamellae were more intensely labeled compared to the connective tissue core of the lamellae, and, similarly, the luminal parts of the cells lining Schlemm's canal were noticeably stained with iPLA 2 . Staining intensity of cPLA 2 was considerably weaker when compared to iPLA 2 . Immunohistochemical staining showed that cPLA 2 expression was slightly higher in uveal and corneoscleral meshwork compared to juxtacanalicular meshwork ( Figure 1D ). The cells lining Schlemm's canal were also faintly stained with cPLA 2 . Moreover, intense staining of iPLA 2 ( Figure 1C ) or cPLA 2 ( Figure  1D ) was also seen in few macrophages. A similar pattern of PLA2s was found in paraffin-embedded and frozen sections of normal human tissue.
RESULTS
Distribution
Localization of sPLA 2 2 , and cPLA 2 in TM samples from eyes with glaucoma. POAG and ExG specimens were collected during deep sclerectomy by removing the inner wall of Schlemm's canal and adjacent juctacanalicular tissue and the TM but leaving the inner meshwork intact (Figure 2) . In general, we found that immunoreaction of sPLA 2 -IIA was much heavier in POAG samples than that in ExG samples ( Figure  3A,B) . In POAG eyes, heavy immunoreactivity was seen in trabecular tissue and around the macrophages, which stained positive for sPLA 2 -IIA ( Figure 3A) . In ExG samples, strong positive PLA 2 -IIA staining was detectable mostly in few macrophage-like cells, and components of extracellular matrix were not so intensively stained compared to POAG samples ( Figure 3B ).
No apparent differences were seen in expression levels or localization of sPLA 2 -V between POAG and ExG samples ( Figure 3C,D) . Staining for sPLA 2 -V was weakly positive. The expression pattern of iPLA 2 was different in POAG and ExG tissues. In POAG eyes, iPLA 2 reactivity was strong in particular areas of tissue where some macrophages also stained positive ( Figure 3E ). In ExG samples, the staining intensity of trabecular tissue was lower compared to POAG eyes ( Figure  3F ), and the strongest staining was in few macrophage-like cells. cPLA 2 immunoreactivity was barely detectable in trabecular tissue. cPLA 2 was stained in few macrophages in POAG ( Figure 3G ) and ExG samples ( Figure 3H) .
Photoshop-based image analysis of sPLA 2 -IIA, sPLA 2 -V, iPLA 2 , and cPLA 2 : Because there were semiquantitative differences in PLA 2 s levels between POAG and ExG samples, we analyzed the samples via Photoshop-based image analysis [55] . Cryostat sections obtained from healthy donor eyes served as controls. The level of sPLA 2 -IIA was significantly higher in POAG samples compared to those in ExG (p<0.001) or in control (p<0.001; Figure 4) . Expression of sPLA 2 -IIA in ExG was also statistically higher (p=0.001) compared to control group. The immunostaining of sPLA 2 -V was slightly higher in POAG samples compared to ExG patients or control, but there were no significant differences between each experimental group (POAG versus ExG, p=0.997; POAG versus control, p=0.301; ExG versus control patients, p=0.317). Expression of iPLA 2 was the highest in control group when compared to POAG (p=0.012) or ExG (p<0.001). In POAG, iPLA 2 level was also significantly higher (p=0.015) compared to ExG. Analysis of cPLA 2 levels showed no significant differences between each experimental group (POAG versus ExG, p=0.367; POAG versus control, p=0.841; ExG versus control patients, p=0.368).
Confocal microscopy: Immunohistochemical studies showed increased number of macrophages in POAG samples when compared to ExG or control ( Figure 5 ). Furthermore, our results showed clear differences in expression levels of sPLA 2 -IIA and iPLA 2 in POAG and ExG samples, and immunohistochemical stainings gave indication that both enzymes might also be present in macrophages. Therefore, we next evaluated whether sPLA 2 -IIA could be in macrophages. We carried out confocal microscopy experiments with double antibody staining for sPLA 2 -IIA and macrophages to demonstrate their colocalization and to provide further support for the macrophage derived sPLA 2 -IIA, especially in POAG specimens ( Figure 6 ). Close examination revealed that some of the macrophages showed no colocalization with sPLA 2 -IIA. Interestingly, immunoreactivity of sPLA 2 -IIA positive macrophages was unevenly distributed in POAG samples. In contrast, the number of macrophages was lower, and sPLA 2 -IIA positive macrophages were rarely found in ExG tissue ( Figure 6 ).
Western blot analysis of PLA 2 s in normal human trabecular meshwork:
No expression of sPLA 2 -IIA or sPLA 2 -V was detected in normal human TM, while about 85 kDa band corresponding to cPLA 2 was detected ( Figure 7) . Furthermore, we detected a minor (about 80 kDa) band corresponding to full-length iPLA 2 and two major (about 55 and 50 kDa) forms. A weak expression of the 40-and 30 kDa forms was also detected. These bands were probably products of alternative splicing or proteolytic degradation.
DISCUSSION
In the present study, we performed immunohistochemistry to determine the expression of PLA 2 s in chamber angles from normal eyes and in surgical specimens from POAG and ExG patients. To our knowledge, this is the first study to examine this expression. Our results demonstrated significant differences in PLA 2 levels. We found (1) sPLA 2 -IIA or sPLA 2 -V was not present in normal TM; (2) iPLA 2 predominated in normal human TM; (3) labeling was strong in the uveal and corneoscleral meshwork; and (4) staining of juxtacanalicular meshwork was only moderate in density. cPLA 2 was also expressed in normal human TM, and the staining intensity of cPLA 2 was considerably weaker when compared to iPLA 2 . Furthermore, expression of macrophage-derived sPLA 2 -IIA was highly expressed in POAG patients compared to normal controls, and expression of iPLA 2 was significantly decreased in ExG (Table 1) Our results showed that sPLA 2 -IIA was significantly increased in glaucomatous tissue compared to normal human TM. sPLA 2 -IIA has an important role in pathological conditions. Accumulation of sPLA 2 -IIA has been demonstrated in human inflammatory diseases such as rheumatoid arthritis, ulcerative colitis, and sepsis [56] [57] [58] . The reaction products of sPLA 2 -IIA are lysophospholipids and AA, which are precursors of potent inflammatory mediators such as platelet-activating factor and eicosanoids. Moreover, sPLA 2 -IIA has a high affinity for several proteoglycans such as glypican, decorin, and versican [59] . The biological actions of sPLA 2 -IIA might be governed by interactions with these proteoglycans in the ECM of the TM. We found the expression of sPLA 2 -IIA was significantly higher in POAG samples when compared to ExG or to control. It seems likely that the sPLA 2 -IIA detected in the TM of POAG patients was primarily macrophage derived because it was not present in healthy TM and expression was seen in macrophages present in the TM. It is well established that macrophages have a great secretory capacity for sPLA 2 -IIA at certain stages of activation [60] . Furthermore, in atherosclerosis, macrophage-specific sPLA 2 -IIA has been shown to increase oxidative stress [61] . Thus our results are in concordance with the growing evidence that inflammation and oxidative stress play an important role in the pathogenesis of glaucoma [51, 62, 63] . In ExG, the lower expression of sPLA 2 -IIA in ExG does not exclude the role of inflammation in the pathogenesis of ExG; it is different because expression and the number of sPLA 2 -IIA positive macrophages are lower when compared to POAG (Table 1) .
Histological and morphologic studies have demonstrated that POAG differs from ExG histopathologically. Loss of structural stability and flexibility of the TM, disorganization of the normal juxtacanalicular tissue structure, and increased trabecular pigmentation are typical histopathologic clinical findings in ExG [14, 15] , whereas POAG is characterized by increased juxtacanalicular plaque and decreased cellularity in the TM [64] . However, mechanisms responsible for these differences in the TM are still unknown. Pathophysiological differences in patients with POAG or ExG was supported further by our finding that expression of iPLA 2 was significantly lower in ExG samples compared to POAG.
Aqueous humor leaves the eye by passing through intratrabecular spaces in the TM before entering Schlemm's canal [50] . Endothelial cells lining Schlemm's canal and the juxtacanalicular tissue of the TM are expected to be the principal site of outflow resistance [50, 65, 66] . The physiological functions of trabecular cells are essential for maintaining a normal IOP. It is believed that changes in trabecular ECM, contractility, and cell density may interfere with the normal function of the TM, thereby leading to glaucoma [50, 64, 67] . It is interesting that iPLA 2 may have the potential to participate in monocyte chemotaxis, relaxation, contraction, apoptosis, and calcium entry [45, 46, 48, 49, 68] . Therefore, iPLA 2 has many functional characteristics that are important for normal TM cells. Our results showed that iPLA 2 was expressed in normal human TM, and therefore, we speculate that iPLA 2 may have a function to maintain normal physiological functions in the TM. The molecular mass of full-length iPLA 2 is about 80 kDa, and it is present predominantly as 50-and 55 kDa forms, which are most likely ankyrin-iPLA 2 splice variants [69] . Traditionally, iPLA 2 has been regarded as a housekeeping enzyme for remodeling and maintenance of membrane phospholipids [42] . Therefore, in ExG eyes, phospholipids remodeling may be dramatically reduced in TM cells. Based on the biological functions proposed for iPLA 2 it is tempting to speculate that dramatic decrease of the enzyme levels in TM cells may enhance the development of these pathological conditions.
During recent years another sPLA 2 , sPLA 2 -V has been implicated in inflammatory signaling. sPLA 2 -V has been shown to be expressed in a species-dependent manner in mouse cells [70] . In humans, sPLA 2 -V appears to substitute for sPLA 2 -IIA in airway epithelium cells [71] . cPLA 2 is the only PLA 2 known to date that is specific for AA at sn-2 position of phospholipids [40] . The activity of cPLA 2 is important during inflammation because AA is the substrate for the production of prostaglandins and leukotrienes. We show in the present study that normal expression of sPLA 2 -V or cPLA 2 is low, and there are no significant differences in levels of sPLA 2 -V or cPLA 2 between healthy, POAG, and ExG tissue. Furthermore, we demonstrated that in normal human TM, cPLA 2 is a protein with molecular weight about 85 kDa, which is a value typically reported for cPLA 2 [18] .
In summary, we have studied the expression of sPLA 2 -IIA, sPLA 2 -V, iPLA 2 , and cPLA 2 in the TM of POAG and ExG and compared these levels to healthy controls. The present study provides new information about the expression of PLA 2 s in glaucoma. Distinct levels of sPLA 2 -IIA and iPLA 2 in POAG and ExG further support the hypothesis that POAG and ExG have different pathogenic mechanisms. During oxidative stress iPLA 2 recognizes and removes oxidized phospholipids from cell membranes. Due to low expression of iPLA 2 in ExG the protection against oxidative stress is much worse compared to that in POAG, enhancing the loss of cell function. IOP tends to be greater in ExG than in POAG, and therefore, decreased expression of iPLA 2 may be a link between increased IOP and loss of structural stability and flexibility of TM cells in ExG. sPLA 2 -IIA has been proposed as an inflammatory marker of cardiovascular disease, and therefore, higher expression of macrophage-derived sPLA 2 -IIA in POAG compared to normal controls supports the view that vascular diseases and POAG may have common pathophysiological mechanisms. Our findings may provide a biochemical basis for the development of new therapeutic agents for POAG and ExG.
